These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16874759)

  • 1. Direct costs of managing Parkinson's disease in India: concerns in a developing country.
    Ragothaman M; Govindappa ST; Rattihalli R; Subbakrishna DK; Muthane UB
    Mov Disord; 2006 Oct; 21(10):1755-8. PubMed ID: 16874759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic burden of Parkinson's disease in a developing country: a retrospective cost analysis in Shanghai, China.
    Wang G; Cheng Q; Zheng R; Tan YY; Sun XK; Zhou HY; Ye XL; Wang Y; Wang Z; Sun BM; Chen SD
    Mov Disord; 2006 Sep; 21(9):1439-43. PubMed ID: 16773620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs of illness and care in Parkinson's disease: an evaluation in six countries.
    von Campenhausen S; Winter Y; Rodrigues e Silva A; Sampaio C; Ruzicka E; Barone P; Poewe W; Guekht A; Mateus C; Pfeiffer KP; Berger K; Skoupa J; Bötzel K; Geiger-Gritsch S; Siebert U; Balzer-Geldsetzer M; Oertel WH; Dodel R; Reese JP
    Eur Neuropsychopharmacol; 2011 Feb; 21(2):180-91. PubMed ID: 20888737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Parkinson's disease: cost-of-illness in an outpatient cohort].
    Reese JP; Winter Y; Balzer-Geldsetzer M; Bötzel K; Eggert K; Oertel WH; Dodel R; Campenhausen Sv
    Gesundheitswesen; 2011 Jan; 73(1):22-9. PubMed ID: 20229454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of health-care costs involved in treating people with and without Parkinson's disease in Southern Sydney, New South Wales, Australia.
    Cordato DJ; Schwartz R; Abbott E; Saunders R; Morfis L
    J Clin Neurosci; 2006 Jul; 13(6):655-8. PubMed ID: 16797991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of illness in Parkinson's disease.
    Huse DM; Schulman K; Orsini L; Castelli-Haley J; Kennedy S; Lenhart G
    Mov Disord; 2005 Nov; 20(11):1449-54. PubMed ID: 16007641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct costs of pulmonary tuberculosis among patients receiving treatment in Bauchi State, Nigeria.
    Umar NA; Abubakar I; Fordham R; Bachmann M
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):835-40. PubMed ID: 22613686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug and treatment costs in Parkinson's disease patients in Sweden.
    Lökk J; Borg S; Svensson J; Persson U; Ljunggren G
    Acta Neurol Scand; 2012 Feb; 125(2):142-7. PubMed ID: 21470194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug costs for patients with Parkinson's disease in two different European countries.
    Vossius C; Gjerstad M; Baas H; Larsen JP
    Acta Neurol Scand; 2006 Apr; 113(4):228-32. PubMed ID: 16542161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs of Parkinson's disease and antiparkinsonian pharmacotherapy: an Italian cohort study.
    Winter Y; von Campenhausen S; Reese JP; Balzer-Geldsetzer M; Longo K; Spiga G; Boetzel K; Eggert K; Oertel WH; Dodel R; Barone P
    Neurodegener Dis; 2010; 7(6):365-72. PubMed ID: 20523028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries.
    Noyes K; Liu H; Li Y; Holloway R; Dick AW
    Mov Disord; 2006 Mar; 21(3):362-72. PubMed ID: 16211621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health insurance and treatment seeking behaviour: evidence from a low-income country.
    Jowett M; Deolalikar A; Martinsson P
    Health Econ; 2004 Sep; 13(9):845-57. PubMed ID: 15362177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of complications and comorbidities on treatment costs and health-related quality of life of patients with Parkinson's disease.
    Bach JP; Riedel O; Klotsche J; Spottke A; Dodel R; Wittchen HU
    J Neurol Sci; 2012 Mar; 314(1-2):41-7. PubMed ID: 22133477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of motor and non-motor symptoms on the direct costs of Parkinson's disease].
    Cubo E; Martínez Martin P; González M; Frades B;
    Neurologia; 2009; 24(1):15-23. PubMed ID: 19003550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Migration, mental health and costs consequences in Romania.
    Miclutia I; Junjan V; Popescu CA; Tigan S
    J Ment Health Policy Econ; 2007 Mar; 10(1):43-50. PubMed ID: 17417046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China.
    Hong Z; Qu B; Wu XT; Yang TH; Zhang Q; Zhou D
    Epilepsia; 2009 Oct; 50(10):2192-8. PubMed ID: 19583782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost of care of schizophrenia: a study of Indian out-patient attenders.
    Grover S; Avasthi A; Chakrabarti S; Bhansali A; Kulhara P
    Acta Psychiatr Scand; 2005 Jul; 112(1):54-63. PubMed ID: 15952946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economic burden of prescription drug use among elderly patients in Ponce, Puerto Rico.
    López-Negrón L; Monsanto-Planadeball HA
    P R Health Sci J; 2006 Jun; 25(2):149-53. PubMed ID: 17203713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing expenditure on health care incurred by diabetic subjects in a developing country: a study from India.
    Ramachandran A; Ramachandran S; Snehalatha C; Augustine C; Murugesan N; Viswanathan V; Kapur A; Williams R
    Diabetes Care; 2007 Feb; 30(2):252-6. PubMed ID: 17259490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.